
In this episode, Peter Penzes, PhD, director of the Center for Autism and Neurodevelopment at Northwestern University Feinberg School of Medicine, discusses a recent discovery of a schizophrenia biomarker and how this research could one day offer earlier diagnosis, more precise treatment, and better outcomes for patients. Learn more about how the field of neurodevelopmental research has evolved over the past decade with major advances in genetics, brain imaging and laboratory models. Large genomic studies have uncovered many more genes associated with risk of developing autism, schizophrenia and related conditions, while new technologies, including brain organoids grown from patients' stem cells, are giving scientists new insight into how these disorders develop and affect brain function.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

How a Tiny Device Could Transform Fetal Surgery with Aimen Shaaban, MD

Is Antimicrobial Resistance Threatening Modern Medicine? with Jennie Kwon, DO

New Insights Into Dopamine with Raj Awatramani, PhD, and Daniel Dombeck, PhD

Improving Testing and Diagnosis of Hepatitis C with Claudia Hawkins, MD, MPH
Free AI-powered recaps of Breakthroughs and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.